TheraCryf Plc

TCF · AIM · Health Care · mcap £3.7m · 0.2p

Beta Briefing, track record and signals & risks are not ready for TheraCryf Plc yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Mar 26

Source: results 28 Sep 26 ↗

Going-concern uncertaintyQualified audit

Revenue: –
Operating profit: −£3.7m
Net income: −£3.5m
Free cash flow: −£2.7m
Net cash: £471k
Market cap: £4.6m
EV / EBIT: –
FCF yield: −57.3%
Price / book: 1.7×

Latest half-year · H1 Sep 25 vs H1 Sep 24 results 03 Dec 25 ↗

Operating profit: −£1.4m
Net income: −£1.3m
Cash from operations: −£721k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

As reported Key figures

Income statement Balance sheet Cash flow

Annual Half-yearly

Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.

Latest report: FY Mar 26 (twelve months to 31 Mar 26), published 28 Sep 26 · read the results ↗

	FY Mar 26 source	FY Mar 25 source
Revenue	—	—
Operating expenses
Operating expenses	(3,460)	(2,007)
Share based compensation	(235)	(117)
Total operating expenses	(3,695)	(2,124)
Operating loss	(3,695)	(2,124)
Finance income	108	5
Other income	19	34
Loss on ordinary activities before taxation	(3,568)	(2,085)
Taxation	37	144
Loss and total comprehensive expense attributable to equity holders of the parent for the year	(3,531)	(1,941)
Loss per share attributable to equity holders of the parent (pence)
Basic loss per share	(0.16)	(0.36)
Diluted loss per share	(0.16)	(0.36)
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
as at 31 March 2026
Group
As at As at
31 March 2026 31 March 2025
Notes £’000 £’000
ASSETS
Non-current assets
Right of Use assets	10	—
Intangible assets	2,514	2,460
Investments in subsidiary undertakings	—	—
Balances due from group undertakings	—	—
Total non-current assets	2,524	2,460
Current assets
Trade and other receivables	554	513
Current tax receivable	193	543
Short-term investments and cash on deposit	1,072	2,005
Cash and cash equivalents	471	2,109
Total current assets	2,290	5,170
Total assets	4,814	7,630
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables	1,675	1,264
Lease liabilities	11	—
Total current liabilities	1,686	1,264
Non-current liabilities
Deferred tax liability	411	398
Total non-current liabilities	411	398
Total liabilities	2,097	1,662
Equity
Ordinary shares	5,372	5,324
Share premium	28,350	28,695
Merger reserve	2,067	2,067
Warrant reserve	342	—
Share based compensation	354	315
Retained deficit	(33,768)	(30,432)
Total equity attributable to equity holders of the parent	2,717	5,969
Total liabilities and equity	4,814	7,630

	H2 Mar 26 calc.	H1 Sep 25£'000 source	H2 Mar 25 calc.	H1 Sep 24£'000 source
Revenue	-	-	-	-
Operating expenses	(2,191)	(1,269)	(778)	(1,229)
Share based compensation	(133)	(102)	(96)	(21)
Total operating expenses	(2,324)	(1,371)	(874)	(1,250)
Operating loss	(2,324)	(1,371)	(874)	(1,250)
Finance income	50	58	-	5
Other income	19	-	34	-
Loss on ordinary activities before taxation	(2,255)	(1,313)	(840)	(1,245)
Taxation	37	-	144	-
Loss and total comprehensive expense attributable to equity holders of the parent for the period	–	(1,313)	–	(1,245)
Basic loss per share	(0.10)	(0.06)	(0.07)	(0.29)
Diluted loss per share	(0.10)	(0.06)	(0.07)	(0.29)

	31 Mar 25£'000 source
ASSETS
Non-current assets
Intangible assets	2,460
Total non-current assets	2,460
Current assets
Trade and other receivables	513
Current tax receivable	543
Short-term investments and cash on deposit	2,005
Cash and cash equivalents	2,109
Total current assets	5,170
Total assets	7,630
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables	1,662
Total current liabilities	1,662
Equity
Ordinary shares	5,324
Share premium	28,695
Merger reserve	2,067
Share based compensation	315
Retained deficit	(30,432)
Total equity attributable to equity holders of the parent	5,969
Total liabilities and equity	7,630

	30 Sep 25£'000 source	31 Mar 25£'000 source	30 Sep 24£'000 source
ASSETS
Non-current assets
Intangible assets	2,456	2,460	1,097
Total non-current assets	2,456	2,460	1,097
Current assets
Trade and other receivables	515	513	408
Current tax receivable	151	543	429
Short-term investments and cash on deposit	2,041	2,005	5
Cash and cash equivalents	1,455	2,109	1,196
Total current assets	4,162	5,170	2,038
Total assets	6,618	7,630	3,135
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables	1,816	1,662	467
Total current liabilities	1,816	1,662	467
Equity
Ordinary shares	5,372	5,324	1,068
Share premium	28,691	28,695	29,040
Merger reserve	2,067	2,067	2,067
Share based compensation	417	315	222
Retained deficit	(31,745)	(30,432)	(29,729)
Total equity attributable to equity holders of the parent	4,802	5,969	2,668
Total liabilities and equity	6,618	7,630	3,135

	FY Mar 25£'000 source
Cash flows from operating activities
Loss before taxation for the period	(2,085)
Interest (income)/expense	(5)
Depreciation and amortisation	69
Share based compensation	117
Net cash outflow from operating activities before changes in working capital and tax received	(1,904)
Changes in working capital
(Increase)/Decrease in trade and other receivables	82
Increase/(Decrease) in trade and other payables	(575)
Cash used in operations	(493)
Taxation received	30
Net cash used in operating activities	(2,367)
Cash flows (used in)/generated from investing activities
Monies placed on fixed-term deposit	(2,005)
Interest income/(expense)	5
Purchase of subsidiary, net of cash acquired	(75)
Net cash (used in)/generated from investing activities	(2,075)
Cash flows from financing activities Gross proceeds from issue of shares	5,152
Cost of fundraise	(605)
Net cash generated from financing activities	4,547
Movements in cash and cash equivalents in the period	105
Cash and cash equivalents at start of period	2,004
Cash and cash equivalents at end of period	2,109
Short-term investments and cash on deposit	2,005
Total cash, cash equivalents and short-term deposits	4,114

	H1 Sep 25£'000 source	H2 Mar 25£'000 calc.	H1 Sep 24£'000 source
Cash flows from operating activities
Loss before taxation for the period	(1,313)	(840)	(1,245)
Interest (income)/expense	(58)	(5)	-
Depreciation and amortisation	4	34	35
Share based compensation	102	96	21
Net cash outflow from operating activities before changes in working capital and tax received	(1,265)	(715)	(1,189)
Changes in working capital
(Increase)/Decrease in trade and other receivables	(2)	(126)	208
Increase/(Decrease) in trade and other payables	154	(167)	(408)
Cash used in operations	152	(293)	(200)
Taxation received	392	30	-
Net cash used in operating activities	(721)	(978)	(1,389)
Cash flows (used in)/generated from investing activities
Monies placed on fixed-term deposit	-	(2,005)	-
Interest income/(expense)	22	10	(5)
Purchase of subsidiary, net of cash acquired	-	-	(75)
Net cash (used in)/generated from investing activities	22	(1,995)	(80)
Cash flows from financing activities Gross proceeds from issue of shares	-	4,251	901
Cost of fundraise	44	(365)	(240)
Net cash generated from financing activities	44	3,886	661
Movements in cash and cash equivalents in the period	(655)	913	(808)
Cash and cash equivalents at start of period	2,109	-	2,004
Cash and cash equivalents at end of period	1,455	913	1,196
Short-term investments and cash on deposit	2,041	2,005	-
Total cash, cash equivalents and short-term deposits	3,496	2,918	1,196

	FY Mar 26	FY Mar 25
Revenue to operating profit
Operating profit	(3.7)	(2.1)
Depreciation (right-of-use)	0.0	–
Share-based payments	(0.2)	(0.1)
Operating profit to net income
Profit before tax	(3.6)	(2.1)
Tax	0.0	0.1
Net income (owners)	(3.5)	(1.9)
Per share
EPS basic	(0.2p)	(0.4p)
EPS diluted	(0.2p)	(0.4p)

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H1 Sep 24
Revenue to operating profit
Operating profit	(2.3)	(1.4)	(0.9)	(1.2)
Share-based payments	(0.3)	0.1	(0.1)	0.0
Operating profit to net income
Profit before tax	(2.3)	(1.3)	(0.8)	(1.2)
Tax	0.0	0.0	0.1	0.0
Net income (owners)	(2.2)	(1.3)	(0.7)	(1.2)
Per share
EPS basic	(0.1p)	(0.1p)	(0.1p)	(0.3p)
EPS diluted	(0.1p)	(0.1p)	(0.1p)	(0.3p)

	FY Mar 26	FY Mar 25
Operating activities
Cash from operations	(2.7)	(2.4)
Financing activities
Lease principal paid	(0.0)	–
Shares issued	–	5.2

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H1 Sep 24
Operating activities
Cash from operations	(1.9)	(0.7)	(1.0)	(1.4)
Financing activities
Shares issued	–	0.0	4.3	0.9

	31 Mar 26	31 Mar 25
Non-current assets
Other intangibles	2.5	2.5
Non-current assets	2.5	2.5
Current assets
Trade receivables	0.6	0.5
Cash	0.5	2.1
Current assets	2.3	5.2
Total assets	4.8	7.6
Current liabilities
Trade payables	1.7	1.3
Lease liabilities, current	0.0	–
Current liabilities	1.7	1.3
Non-current liabilities
Non-current liabilities	0.4	0.4
Total liabilities	2.1	1.7
Equity
Total equity	2.7	6.0

	31 Mar 26	30 Sep 25	31 Mar 25	30 Sep 24
Non-current assets
Other intangibles	2.5	2.5	2.5	1.1
Non-current assets	2.5	2.5	2.5	1.1
Current assets
Trade receivables	0.6	0.5	0.5	0.4
Cash	0.5	1.5	2.1	1.2
Current assets	2.3	4.2	5.2	2.0
Total assets	4.8	6.6	7.6	3.1
Current liabilities
Trade payables	1.7	1.8	1.3	0.5
Lease liabilities, current	0.0	–	–	–
Current liabilities	1.7	1.8	1.3	0.5
Non-current liabilities
Non-current liabilities	0.4	–	0.4	–
Total liabilities	2.1	–	1.7	–
Equity
Total equity	2.7	4.8	6.0	2.7

Read automatically from each results announcement. Check the source before relying on a figure.

Company filings. Not investment advice.